Advance Nanotech Announces Collaboration with Dr. Molly Stevens in the Area of Nanoparticle Composites for Drug Delivery.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Advance Nanotech, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :AVNA AVNA Atrioventricular Node Artery ), a company that specializes in the acquisition and commercialization of nanotechnologies, announced the funding of the latest research of Dr. Molly Stevens who was named in the Top 100 Young Innovators in the world by Technology Review Magazine. The collaboration between Advance Nanotech and Dr. Stevens of Imperial College London History Imperial College was founded in 1907, with the merger of the City and Guilds College, the Royal School of Mines and the Royal College of Science (all of which had been founded between 1845 and 1878) with these entities continuing to exist as "constituent colleges". will develop composites incorporating nanoparticles for drug delivery applications, a project inspired by the intelligence of biological systems in sensing changes in their environment. These nanoparticle composites will be capable of drug delivery in previously inaccessible parts of the human body by detecting physiological changes in the human body triggering the release of stored drugs. A drug delivery device created using this research could be more sensitive and offer more control over a multitude of different drug dosages. This breakthrough in next-generation drug delivery shall utilize Dr. Stevens's expertise in rational peptide design to incorporate specific pH, enzymes and temperature triggers within the composites enabling a new level of control over the release of encapsulated encapsulated Localized Oncology adjective Confined to a specific area, surrounded by a thin layer of fibrous tissue; encapsulation generally refers to a tumor confined to a specific area, surrounded by a capsule. See Islet encapsulation. drugs. The importance of drug delivery technology to the overall market success of a drug is increasing. Pharmaceutical companies may substantially extend the period of exclusivity (and the competitive edge) of their products that are about to lose patent by delivering them in a novel way. Third party payers are excited about the potential cost savings of improved patient compliance and better outcomes. Furthermore, delivery considerations will likely be the key to making biopharmaceuticals and other macromolecular mac·ro·mol·e·cule n. A very large molecule, such as a polymer or protein, consisting of many smaller structural units linked together. Also called supermolecule. therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. derived from the Human Genome The human genome is the genome of Homo sapiens, which is composed of 24 distinct pairs of chromosomes (22 autosomal + X + Y) with a total of approximately 3 billion DNA base pairs containing an estimated 20,000–25,000 genes. Project into workable clinical tools. About Advance Nanotech Inc.: Advance Nanotech, Inc. (``Advance'') commercializes innovative nanotechnologies. Operating in three areas, electronics, biopharma and materials, Advance leverages relationships with financial and development resources to enable a product focused fast-track commercialization of nanotechnology. Advance has established relationships with academic institutions throughout the world that are at the forefront of nanotechnology research and development. Advance's objective is to invest in patented innovation to bridge early stage product development with valuable markets. Advance Nanotech is quoted on the Over-The-Counter Bulletin Board under the symbol "AVNA.OB." For more information on Advance Nanotech, visit the company's website at http://www.advancenanotech.com. About Imperial College London: Consistently rated in the top three UK university institutions, Imperial College London is a world leading science-based university whose reputation for excellence in teaching and research attracts students (11,000) and staff (6,000) of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and management and delivers practical solutions that enhance the quality of life and the environment - underpinned by a dynamic enterprise culture. Website: www.imperial.ac.uk Advance Nanotech Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement This press release may contain statements of a forward-looking nature relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc future events. These forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with those inherent in the early stage of Advance Nanotech's technologies under development; acquisitions, divestitures, mergers, licenses or strategic initiatives that change Advance Nanotech's business, structure or projections; the development of competing products; uncertainties related to Advance Nanotech's dependence on third parties and partners, and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Advance Nanotech, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion